Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Vaccine ; 40(46): 6631-6639, 2022 11 02.
Artigo em Inglês | MEDLINE | ID: mdl-36210251

RESUMO

Rotavirus vaccination has been shown to reduce rotavirus burden in many countries, but the long-term magnitude of vaccine impacts is unclear, particularly in low-income countries. We use a transmission model to estimate the long-term impact of rotavirus vaccination on deaths and disability adjusted life years (DALYs) from 2006 to 2034 for 112 low- and middle-income countries. We also explore the predicted effectiveness of a one- vs two- dose series and the relative contribution of direct vs indirect effects to overall impacts. To validate the model, we compare predicted percent reductions in severe rotavirus cases with the percent reduction in rotavirus positivity among gastroenteritis hospital admissions for 10 countries with pre- and post-vaccine introduction data. We estimate that vaccination would reduce deaths from rotavirus by 49.1 % (95 % UI: 46.6-54.3 %) by 2034 under realistic coverage scenarios, compared to a scenario without vaccination. Most of this benefit is due to direct benefit to vaccinated individuals (explaining 69-97 % of the overall impact), but indirect protection also appears to enhance impacts. We find that a one-dose schedule would only be about 57 % as effective as a two-dose schedule 12 years after vaccine introduction. Our model closely reproduced observed reductions in rotavirus positivity in the first few years after vaccine introduction in select countries. Rotavirus vaccination is likely to have a substantial impact on rotavirus gastroenteritis and its mortality burden. To sustain this benefit, the complete series of doses is needed.


Assuntos
Gastroenterite , Infecções por Rotavirus , Vacinas contra Rotavirus , Rotavirus , Humanos , Lactente , Infecções por Rotavirus/prevenção & controle , Gastroenterite/prevenção & controle , Vacinação , Análise Custo-Benefício
2.
Reprod Sci ; 16(2): 152-61, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19208783

RESUMO

Endometriosis, defined as the ectopic presence of endometrial-like cells, is associated with infertility and pelvic pain in women. Whereas pathogenesis and spontaneous evolution of endometriosis are still poorly understood, recurrences after surgical therapy or after medical treatment are common. Spontaneous endometriosis occurs only in women and in nonhuman primates (NHPs). Inbred rhesus monkeys kept in colonies offer an attractive preclinical model to study the inheritance of spontaneous endometriosis. Baboons with spontaneous or induced endometriosis appear to be the best NHP model to study pathogenesis, pathophysiology, spontaneous evolution and new medical treatment options. In baboons, induction of endometriosis after intrapelvic injection of menstrual endometrium leads to biological changes in peritoneal cavity and in endometrium. This induction process may allows the study of cause-effect relationships which may lead to the discovery of new biomarkers for the development of new non-invasive diagnostic tests and drugs that may prevent or treat endometriosis.


Assuntos
Pesquisa Biomédica , Modelos Animais de Doenças , Endometriose , Macaca mulatta , Papio , Animais , Pesquisa Biomédica/economia , Pesquisa Biomédica/ética , Endometriose/diagnóstico , Endometriose/etiologia , Endometriose/fisiopatologia , Endometriose/terapia , Feminino , Fármacos para a Fertilidade Feminina/farmacologia , Humanos , Fatores Imunológicos/farmacologia , Imunossupressores/farmacologia , Infertilidade Feminina/etiologia , Infertilidade Feminina/fisiopatologia , Inflamação/etiologia , Inflamação/fisiopatologia , Menstruação , Dor Pélvica/etiologia , Dor Pélvica/fisiopatologia , Reprodutibilidade dos Testes , Reprodução , Fatores de Risco , Índice de Gravidade de Doença , Especificidade da Espécie
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA